Danaparoid
Danaparoid
Danaparoid (pronunciation: /dænəˈpærɔɪd/) is a type of anticoagulant medication that is used to prevent and treat thrombosis. It is a low molecular weight heparinoid that is derived from porcine intestinal mucosa.
Etymology
The term "Danaparoid" is derived from the name of the company that first developed the drug, Organon Teknika, which was based in the Netherlands. The "dana" part of the name is an acronym for Dutch Anticoagulant, and the "paroid" part of the name is a reference to the drug's similarity to heparin.
Usage
Danaparoid is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the treatment of heparin-induced thrombocytopenia (HIT).
Mechanism of Action
Danaparoid works by inhibiting the activity of certain clotting factors in the blood, specifically factor Xa and factor IIa. This prevents the formation of blood clots.
Related Terms
- Anticoagulant
- Thrombosis
- Heparinoid
- Deep vein thrombosis
- Pulmonary embolism
- Heparin-induced thrombocytopenia
- Clotting factors
See Also
External links
- Medical encyclopedia article on Danaparoid
- Wikipedia's article - Danaparoid
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski